Celltrion Obtains Final Sales Approval for Remsima SC in 31 European Countries
[Asia Economy Reporter Kim Heung-soon] Celltrion announced on the 27th that it has obtained approval from the European Commission (EC) for the sale of the Ramcima SC formulation for new indications including adult Crohn's disease, adult ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis in 31 European countries.
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025050713592847164_1746593968.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Wearing a Leather Jacket in 30-Degree Heat, Jensen Huang Enjoys Street Food as Beijing's 'Mukbang Star': 'It's Delicious'"
- "Drink Three Cups of Coffee and Stay Up All Night Before the Test"... Manual of Insurance Planner Who Collected 1 Billion Won in Payouts
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
